Swisslog Healthcare Acquires Talyst
Combined Swisslog and Talyst portfolio creates global leadership in acute-care pharmacy services and solutions. The acquisition reinforces Swisslog Healthcare’s commitment in North America and globally to lead change that increases healthcare efficiency, enhances the quality of care and improves patient outcomes.
8. August 2017
Healthcare providers around the world share similar challenges with delivering medications safely and efficiently. The acquisition creates an unmatched portfolio of inpatient and outpatient pharmacy solutions that transform health systems’ performance. Talyst’s AutoCarousel, AutoPack and AutoSecure Storage Solutions represent the best-of-breed in current generation pharmacy automation technologies.
“Swisslog Healthcare and Talyst are well known for developing innovative automation and software solutions,” said Stephan Sonderegger, CEO – Swisslog Healthcare. “The two companies share a similar mission and vision and the Talyst portfolio of enterprise software and pharmacy automation products completes Swisslog Healthcare’s pharmacy automation offering in North America. This acquisition adds critical components to our solutions strategy of providing customers with end-to-end integration for the medication supply chain across the continuum of care.”
Founded in 2002, Talyst was recognized by KLAS Research’s most recent (2016) Pharmacy Report as a leader in Enterprise Medication Management Software that minimizes medication spending. “Talyst develops customer-centric technologies that enable providers to deliver better patient care. Our culture of innovation and accountability aligns well with Swisslog Healthcare,” notes Carla Corkern, Talyst CEO. “With Swisslog we can now scale our solutions globally, taking advantage of their sales reach, manufacturing, and R&D facilities across North America, EMEA and Asia. We’re excited to be part of a strong and dedicated organization building towards an important differentiated vision for health systems and hospital pharmacies.”
“Swisslog Healthcare and Talyst customers will benefit from a total inpatient pharmacy automation offering fully integrated with the Swisslog transport automation portfolio of pneumatic tube systems installed in 2,300 hospitals in North America. The acquisition expands our product offerings which, combined with our manufacturing expertise and extensive field service network, gives health systems unprecedented access to a complete solution including data analytics, pharmacy automation and transport automation,” notes Sonderegger. “Our respective customers will benefit from a compelling technology and services road map that leverages the extensive resources and capabilities of the combined companies.”
With the acquisition, the Talyst executive team along with the rest of the company will join the Swisslog Healthcare organization. Talyst CEO and Chairman of the Board, Carla Corkern, has elected to pursue other opportunities. The Talyst Seattle-area headquarters will become an important technology, product and business development hub for Swisslog Healthcare North America. Swisslog Healthcare is building a new state-of-the-art North America manufacturing facility and US headquarters in the Denver-Boulder area, which is planned for occupation in early 2018.